Garmin Q3 profit beats estimates on margin expansion; raises outlook

By Reuters News


Overview

  • Switzerland-based GPS device maker's Q3 revenue rose 12% yr/yr, meeting analyst expectations

  • Q3 operating income and net income both beat analyst estimates

  • Company raised full-year 2026 guidance after record Q3 results


Outlook

  • Garmin raises 2026 revenue guidance to $8.15 bln

  • Company now expects 2026 pro forma EPS of $10.80

  • Garmin sees 2026 gross margin at 61.0% and operating margin at 29.0%


Result Drivers

  • PRODUCT AND MARKET STRENGTH - Co said broad-based demand and new product launches contributed to record results, per CEO Cliff Pemble

  • MARGIN EXPANSION - Higher gross margin attributed to favorable segment mix, lower product cost, and tariff refunds

  • SEGMENT GROWTH - Fitness, outdoor, and marine segments saw double-digit revenue growth, led by wearables, adventure watches, and sonar products


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Meet

$1.99 bln

$1.99 bln (4 Analysts)

Q3 Pro forma EPS

$2.76

Q3 EPS

$2.80

Q3 Net Income

Beat

$541.66 mln

$468.43 mln (4 Analysts)

Q3 Gross Margin

63.30%

Q3 Operating income

Beat

$611.65 mln

$535.03 mln (4 Analysts)

Q3 Pretax Profit

$661.12 mln


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 6 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the communications & networking peer group is "buy."

  • Wall Street's median 12-month price target for Garmin Ltd. is $293.00, about 1.3% above its October 27 closing price of $289.34

  • The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 24 three months ago


Reuters Recommended Reads

  • Oct 27 - Switzerland's INFICON Q3 sales jump, lifts FY outlook on firm semiconductor demand

  • Oct 27 - Logitech beats profit forecast as sales of gaming, conferencing products rise

  • Oct 27 - Novartis slightly misses Q3 net sales estimates, but tops core EPS view


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk